Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Levosimendan | hsa00071 | Fatty acid degradation | 2.52E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | | Levosimendan | hsa00190 | Oxidative phosphorylation | 1.07E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Levosimendan | hsa00500 | Starch and sucrose metabolism | 1.07E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Levosimendan | hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 4.77E-02 | 1 | Q7LGA3 | HS2ST1 | More | | Levosimendan | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.12E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Levosimendan | hsa00730 | Thiamine metabolism | 8.96E-04 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Levosimendan | hsa00760 | Nicotinate and nicotinamide metabolism | 3.52E-02 | 1 | P21589 | NT5E | More | | Levosimendan | hsa00770 | Pantothenate and CoA biosynthesis | 2.27E-02 | 2 | O95498, O95497 | VNN2, VNN1 | More | | Levosimendan | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.77E-04 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Levosimendan | hsa01100 | Metabolic pathways | 3.52E-02 | 23 | P05089, O95455, P21953, P32320, P11766, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, Q08477, P15907, Q9UNP4, P37837, P32321, Q9BPW9, Q9UHY7, P43490, P46976, P06737 | ARG1, TGDS, BCKDHB, CDA, ADH5, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, CYP4F3, ST6GAL1, ST3GAL5, TALDO1, DCTD, DHRS9, ENOPH1, PBEF1, GYG1, PYGL | More | | Levosimendan | hsa01524 | Platinum drug resistance | 4.45E-02 | 4 | P10415, Q13489, P78417, P43246 | BCL2, BIRC3, GSTO1, MSH2 | More | | Levosimendan | hsa02010 | ABC transporters | 4.89E-02 | 1 | Q99758 | ABCA3 | More | | Levosimendan | hsa03040 | Spliceosome | 6.64E-08 | 13 | Q14562, O43143, O60508, P17844, P08579, O75940, Q15365, O75494, Q07955, Q01130, Q13243, P11142, O43447 | DHX8, DHX15, CDC40, DDX5, SNRPB2, SMNDC1, PCBP1, FUSIP1, SFRS1, SFRS2, SFRS5, HSPA8, PPIH | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.853 | P0DP25 | CALM3 | Calmodulin-3 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | P0DP24 | CALM2 | Calmodulin-2 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | P0DP23 | CALM1 | Calmodulin-1 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.818 | P0DP25 | CALM3 | Calmodulin-3 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P0DP24 | CALM2 | Calmodulin-2 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P0DP23 | CALM1 | Calmodulin-1 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P0DP25 | CALM3 | Calmodulin-3 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | P0DP24 | CALM2 | Calmodulin-2 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | P0DP23 | CALM1 | Calmodulin-1 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | P0DP24 | CALM2 | Calmodulin-2 | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.734 | P0DP25 | CALM3 | Calmodulin-3 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | P0DP24 | CALM2 | Calmodulin-2 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | P0DP23 | CALM1 | Calmodulin-1 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O75940 | SMNDC1 | Survival of motor neuron-related-splicing factor 30 | 0.786 | P0DP24 | CALM2 | Calmodulin-2 | Q15365 | PCBP1 | Poly(rC)-binding protein 1 | 0.75 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O75494 | FUSIP1 | Serine/arginine-rich splicing factor 10 | 0.73 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.776 | P0DP25 | CALM3 | Calmodulin-3 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P0DP24 | CALM2 | Calmodulin-2 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P0DP23 | CALM1 | Calmodulin-1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.758 | P0DP25 | CALM3 | Calmodulin-3 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P0DP24 | CALM2 | Calmodulin-2 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P0DP23 | CALM1 | Calmodulin-1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.87 | P0DP25 | CALM3 | Calmodulin-3 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP24 | CALM2 | Calmodulin-2 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP23 | CALM1 | Calmodulin-1 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP25 | CALM3 | Calmodulin-3 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | P0DP24 | CALM2 | Calmodulin-2 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | P0DP23 | CALM1 | Calmodulin-1 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | P0DP25 | CALM3 | Calmodulin-3 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 | P0DP24 | CALM2 | Calmodulin-2 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 | P0DP23 | CALM1 | Calmodulin-1 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 |
| Levosimendan | hsa04014 | Ras signaling pathway | 1.72E-04 | 10 | P31751, P20827, Q9NRA1, P49767, Q13009, P17252, Q15311, P0DP23, P62873, P19174 | AKT2, EFNA1, PDGFC, VEGFC, TIAM1, PRKCA, RALBP1, CALM1, GNB1, PLCG1 | More | | Levosimendan | hsa04015 | Rap1 signaling pathway | 8.16E-04 | 10 | P20827, Q9NRA1, P49767, Q13009, Q08828, P51828, P31751, P0DP23, P17252, P19174 | EFNA1, PDGFC, VEGFC, TIAM1, ADCY1, ADCY7, AKT2, CALM1, PRKCA, PLCG1 | More | | Levosimendan | hsa04020 | Calcium signaling pathway | 7.32E-08 | 13 | P27987, Q08828, Q13557, P17252, O15399, P19174, P61073, P0DP23, P51828, P20020, P23634, Q9NRA1, P49767 | ITPKB, ADCY1, CAMK2D, PRKCA, GRIN2D, PLCG1, CXCR4, CALM1, ADCY7, ATP2B1, ATP2B4, PDGFC, VEGFC | More | | Levosimendan | hsa04024 | cAMP signaling pathway | 3.01E-03 | 9 | Q08828, P51828, P31751, P0DP23, P23634, Q13557, Q13370, O15399, Q13009 | ADCY1, ADCY7, AKT2, CALM1, ATP2B4, CAMK2D, PDE3B, GRIN2D, TIAM1 | More | | Levosimendan | hsa04060 | Cytokine-cytokine receptor interaction | 4.71E-02 | 2 | P78552, O75509 | IL13RA1, TNFRSF21 | More | | Levosimendan | hsa04062 | Chemokine signaling pathway | 2.04E-02 | 10 | P51684, Q8NHW4, P19174, P62873, Q08828, P51828, Q13009, P14598, P42224, P31751 | CCR6, CCL4L2, PLCG1, GNB1, ADCY1, ADCY7, TIAM1, NCF1, STAT1, AKT2 | More | | Levosimendan | hsa04064 | NF-kappa B signaling pathway | 2.28E-04 | 9 | P10415, Q13489, P51617, P01584, P29965, P19174, O75293, Q8NHW4, Q9NQC7 | BCL2, BIRC3, IRAK1, IL1B, CD40LG, PLCG1, GADD45B, CCL4L2, CYLD | More | | Levosimendan | hsa04070 | Phosphatidylinositol signaling system | 7.22E-05 | 6 | P19174, P0DP23, P23743, P48426, P27987, P17252 | PLCG1, CALM1, DGKA, PIP4K2A, ITPKB, PRKCA | More | | Levosimendan | hsa04071 | Sphingolipid signaling pathway | 3.36E-02 | 6 | P17252, Q13510, Q13362, P10415, Q9UQC2, P01042 | PRKCA, ASAH1, PPP2R5C, BCL2, GAB2, KNG1 | More | | Levosimendan | hsa04072 | Phospholipase D signaling pathway | 2.44E-03 | 10 | P31751, Q92529, P19174, P17252, Q14344, Q15438, Q08828, P51828, P23743, P00734 | AKT2, SHC3, PLCG1, PRKCA, GNA13, PSCD1, ADCY1, ADCY7, DGKA, F2 | More | | Levosimendan | hsa04140 | Autophagy - animal | 2.58E-02 | 7 | P31751, Q7L523, Q96RR4, O75460, P10415, Q96GC9, Q8TEV9 | AKT2, RRAGA, CAMKK2, ERN1, BCL2, TMEM49, SMCR8 | More | | Levosimendan | hsa04144 | Endocytosis | 8.99E-03 | 12 | P11142, Q9H444, O43633, O75351, Q9NZZ3, Q15438, Q14161, P14784, Q96QK1, Q9UMY4, Q9Y5X3, Q9UNH7 | HSPA8, CHMP4B, CHMP2A, VPS4B, CHMP5, PSCD1, GIT2, IL2RB, VPS35, SNX12, SNX5, SNX6 | More | | Levosimendan | hsa04145 | Phagosome | 1.22E-02 | 7 | P60709, P63261, Q15080, P14598, Q13509, P68371, Q13488 | ACTB, ACTG1, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1 | More | | Levosimendan | hsa04150 | mTOR signaling pathway | 2.23E-02 | 3 | P42338, Q13322, P49841 | PIK3CB, GRB10, GSK3B | More | | Levosimendan | hsa04151 | PI3K-Akt signaling pathway | 4.68E-03 | 18 | O43521, P27348, P20827, P49767, Q13362, P08238, P62873, P16144, P48551, P14784, P23458, P01568, P15336, P18848, P10415, P17252, Q16513, Q6ZUJ8 | BCL2L11, YWHAQ, EFNA1, VEGFC, PPP2R5C, HSP90AB1, GNB1, ITGB4, IFNAR2, IL2RB, JAK1, IFNA21, ATF2, ATF4, BCL2, PRKCA, PKN2, PIK3AP1 | More | | Levosimendan | hsa04210 | Apoptosis | 6.18E-03 | 3 | P07384, P60709, P63261 | CAPN1, ACTB, ACTG1 | More | | Levosimendan | hsa04217 | Necroptosis | 1.82E-09 | 17 | P01568, P23458, Q13489, Q9NQC7, P42224, P08238, P01584, P0C0S5, Q6FI13, Q93077, P10415, Q13557, Q9H444, O43633, Q9NZZ3, O75351, Q08752 | IFNA21, JAK1, BIRC3, CYLD, STAT1, HSP90AB1, IL1B, H2AFZ, H2AC18; H2AC19, HIST1H2AC, BCL2, CAMK2D, CHMP4B, CHMP2A, CHMP5, VPS4B, PPID | More | | Levosimendan | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.43E-06 | 11 | P09493, Q08828, P51828, P31751, P18848, Q13362, P0DP23, Q13557, P17252, P10415, P23634 | TPM1, ADCY1, ADCY7, AKT2, ATF4, PPP2R5C, CALM1, CAMK2D, PRKCA, BCL2, ATP2B4 | More | | Levosimendan | hsa04360 | Axon guidance | 7.54E-05 | 8 | P61073, P16333, P20827, O95631, P17252, Q13557, P23528, P19174 | CXCR4, NCK1, EFNA1, NTN1, PRKCA, CAMK2D, CFL1, PLCG1 | More | | Levosimendan | hsa04371 | Apelin signaling pathway | 3.08E-02 | 7 | P62873, P31751, Q08828, P51828, Q13370, Q13485, P0DP23 | GNB1, AKT2, ADCY1, ADCY7, PDE3B, SMAD4, CALM1 | More | | Levosimendan | hsa04380 | Osteoclast differentiation | 6.79E-03 | 11 | Q9NQC7, Q9UQC2, P23458, P42224, P06239, P42338, P01584, P14778, Q15080, P14598, Q8N149 | CYLD, GAB2, JAK1, STAT1, LCK, PIK3CB, IL1B, IL1R1, NCF4, NCF1, LILRA2 | More | | Levosimendan | hsa04390 | Hippo signaling pathway | 2.80E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Levosimendan | hsa04510 | Focal adhesion | 3.76E-02 | 7 | P16144, O75369, Q15942, P17252, Q13489, P10415, P49767 | ITGB4, FLNB, ZYX, PRKCA, BIRC3, BCL2, VEGFC | More | | Levosimendan | hsa04520 | Adherens junction | 1.58E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Levosimendan | hsa04530 | Tight junction | 3.88E-03 | 3 | P60709, P63261, P60660 | ACTB, ACTG1, MYL6 | More | | Levosimendan | hsa04540 | Gap junction | 2.22E-03 | 6 | P17252, Q13509, P68371, Q08828, P51828, Q9NRA1 | PRKCA, TUBB3, TUBB2C, ADCY1, ADCY7, PDGFC | More | | Levosimendan | hsa04611 | Platelet activation | 2.61E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Levosimendan | hsa04620 | Toll-like receptor signaling pathway | 1.33E-02 | 5 | P51617, P01568, P31751, P42224, Q8NHW4 | IRAK1, IFNA21, AKT2, STAT1, CCL4L2 | More | | Levosimendan | hsa04621 | NOD-like receptor signaling pathway | 1.89E-03 | 16 | P01584, P08238, Q16539, P23458, P42224, P01568, Q9H3M7, Q13489, P10599, Q9H1Y0, P43490, O00463, P10415, P01375, P09341, P12838 | IL1B, HSP90AB1, MAPK14, JAK1, STAT1, IFNA21, TXNIP, BIRC3, TXN, ATG5, PBEF1, TRAF5, BCL2, TNF, CXCL1, DEFA4 | More | | Levosimendan | hsa04623 | Cytosolic DNA-sensing pathway | 3.53E-03 | 3 | P01568, P25963, Q8NHW4 | IFNA21, NFKBIA, CCL4L2 | More | | Levosimendan | hsa04630 | JAK-STAT signaling pathway | 1.16E-02 | 8 | P31751, P10415, P42224, P23458, P14784, P16871, Q13651, P01568 | AKT2, BCL2, STAT1, JAK1, IL2RB, IL7R, IL10RA, IFNA21 | More | | Levosimendan | hsa04657 | IL-17 signaling pathway | 8.67E-04 | 11 | P25963, P08238, O00463, Q07955, Q16539, P49841, P09341, P14780, P04141, P01375, P06702 | NFKBIA, HSP90AB1, TRAF5, SFRS1, MAPK14, GSK3B, CXCL1, MMP9, CSF2, TNF, S100A9 | More | | Levosimendan | hsa04659 | Th17 cell differentiation | 4.12E-02 | 4 | P06239, P14784, P14778, P07766 | LCK, IL2RB, IL1R1, CD3E | More | | Levosimendan | hsa04660 | T cell receptor signaling pathway | 3.80E-02 | 6 | P04141, P25963, P10747, P19174, P16333, P29350 | CSF2, NFKBIA, CD28, PLCG1, NCK1, PTPN6 | More | | Levosimendan | hsa04662 | B cell receptor signaling pathway | 7.09E-04 | 6 | P25963, P49841, P42338, P20023, P21854, Q8N149 | NFKBIA, GSK3B, PIK3CB, CR2, CD72, LILRA2 | More | | Levosimendan | hsa04666 | Fc gamma R-mediated phagocytosis | 2.78E-02 | 6 | P08575, P19174, P23528, Q9UQC2, P14598, P17252 | PTPRC, PLCG1, CFL1, GAB2, NCF1, PRKCA | More | | Levosimendan | hsa04670 | Leukocyte transendothelial migration | 4.07E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Levosimendan | hsa04713 | Circadian entrainment | 5.73E-06 | 8 | O15399, P0DP23, Q13557, P17252, P62873, Q08828, P51828, O15055 | GRIN2D, CALM1, CAMK2D, PRKCA, GNB1, ADCY1, ADCY7, PER2 | More | | Levosimendan | hsa04714 | Thermogenesis | 3.64E-04 | 4 | P15336, P60709, P63261, P36542 | ATF2, ACTB, ACTG1, ATP5C1 | More | | Levosimendan | hsa04720 | Long-term potentiation | 3.26E-03 | 6 | P17252, Q13557, P0DP23, P18848, O15399, Q08828 | PRKCA, CAMK2D, CALM1, ATF4, GRIN2D, ADCY1 | More | | Levosimendan | hsa04724 | Glutamatergic synapse | 4.08E-02 | 5 | O15399, Q08828, P51828, P17252, P62873 | GRIN2D, ADCY1, ADCY7, PRKCA, GNB1 | More | | Levosimendan | hsa04725 | Cholinergic synapse | 4.42E-04 | 8 | Q08828, P51828, P17252, P62873, P18848, Q13557, P31751, P10415 | ADCY1, ADCY7, PRKCA, GNB1, ATF4, CAMK2D, AKT2, BCL2 | More | | Levosimendan | hsa04727 | GABAergic synapse | 4.08E-02 | 5 | Q08828, P51828, P62873, P46459, P17252 | ADCY1, ADCY7, GNB1, NSF, PRKCA | More | | Levosimendan | hsa04730 | Long-term depression | 3.52E-02 | 1 | Q14344 | GNA13 | More | | Levosimendan | hsa04740 | Olfactory transduction | 2.61E-02 | 3 | P62873, Q13557, P0DP23 | GNB1, CAMK2D, CALM1 | More | | Levosimendan | hsa04744 | Phototransduction | 2.17E-07 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Levosimendan | hsa04750 | Inflammatory mediator regulation of TRP channels | 5.09E-06 | 11 | P14778, P01584, Q08828, P51828, Q13557, P19174, P42338, P17252, P24723, P0DP23, P01042 | IL1R1, IL1B, ADCY1, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCA, PRKCH, CALM1, KNG1 | More | | Levosimendan | hsa04911 | Insulin secretion | 3.47E-02 | 4 | Q08828, P17252, P18848, Q13557 | ADCY1, PRKCA, ATF4, CAMK2D | More | | Levosimendan | hsa04912 | GnRH signaling pathway | 2.85E-02 | 5 | P17252, Q08828, P18848, Q13557, P0DP23 | PRKCA, ADCY1, ATF4, CAMK2D, CALM1 | More | | Levosimendan | hsa04914 | Progesterone-mediated oocyte maturation | 3.26E-02 | 6 | Q08828, P51828, P31751, Q13370, Q9UJX4, P08238 | ADCY1, ADCY7, AKT2, PDE3B, ANAPC5, HSP90AB1 | More | | Levosimendan | hsa04915 | Estrogen signaling pathway | 3.28E-03 | 9 | P18848, Q08828, P51828, P31751, P08238, P11142, P0DP23, Q15788, P10415 | ATF4, ADCY1, ADCY7, AKT2, HSP90AB1, HSPA8, CALM1, NCOA1, BCL2 | More | | Levosimendan | hsa04919 | Thyroid hormone signaling pathway | 3.20E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Levosimendan | hsa04921 | Oxytocin signaling pathway | 1.77E-03 | 3 | P60660, P60709, P63261 | MYL6, ACTB, ACTG1 | More | | Levosimendan | hsa04923 | Regulation of lipolysis in adipocytes | 2.12E-02 | 4 | Q08828, P51828, Q13370, P31751 | ADCY1, ADCY7, PDE3B, AKT2 | More | | Levosimendan | hsa04925 | Aldosterone synthesis and secretion | 6.45E-04 | 7 | P18848, Q08828, P51828, P0DP23, P17252, Q13557, P23634 | ATF4, ADCY1, ADCY7, CALM1, PRKCA, CAMK2D, ATP2B4 | More | | Levosimendan | hsa04929 | GnRH secretion | 3.63E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Levosimendan | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.13E-07 | 9 | Q13485, P01584, P42224, P10415, P31751, Q12778, P49767, P17252, P19174 | SMAD4, IL1B, STAT1, BCL2, AKT2, FOXO1, VEGFC, PRKCA, PLCG1 | More | | Levosimendan | hsa04935 | Growth hormone synthesis, secretion and action | 3.93E-02 | 6 | P19174, Q08828, P51828, P17252, P31751, P42224 | PLCG1, ADCY1, ADCY7, PRKCA, AKT2, STAT1 | More | | Levosimendan | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.38E-02 | 1 | P48048 | KCNJ1 | More | | Levosimendan | hsa04970 | Salivary secretion | 1.35E-03 | 5 | Q08828, P51828, P23634, P17252, P0DP23 | ADCY1, ADCY7, ATP2B4, PRKCA, CALM1 | More | | Levosimendan | hsa04971 | Gastric acid secretion | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Levosimendan | hsa04972 | Pancreatic secretion | 1.92E-03 | 5 | P23634, P17252, Q08828, P51828, P62491 | ATP2B4, PRKCA, ADCY1, ADCY7, RAB11A | More | | Levosimendan | hsa04973 | Carbohydrate digestion and absorption | 4.12E-03 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Levosimendan | hsa05012 | Parkinson disease | 3.12E-02 | 6 | Q16718, O14521, P19174, P0DP23, Q13509, P68371 | NDUFA5, SDHD, PLCG1, CALM1, TUBB3, TUBB2C | More | | Levosimendan | hsa05014 | Amyotrophic lateral sclerosis | 2.98E-02 | 3 | P36542, P60709, P63261 | ATP5C1, ACTB, ACTG1 | More | | Levosimendan | hsa05017 | Spinocerebellar ataxia | 1.75E-02 | 7 | P17252, O75460, Q8TB72, O15399, P31751, P28070, O00232 | PRKCA, ERN1, PUM2, GRIN2D, AKT2, PSMB4, PSMD12 | More | | Levosimendan | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.29E-02 | 9 | Q13509, P68371, Q16718, O14521, Q13561, P19174, P17252, Q08752, P0DP23 | TUBB3, TUBB2C, NDUFA5, SDHD, DCTN2, PLCG1, PRKCA, PPID, CALM1 | More | | Levosimendan | hsa05031 | Amphetamine addiction | 2.85E-02 | 5 | O15399, P0DP23, Q13557, P18848, P17252 | GRIN2D, CALM1, CAMK2D, ATF4, PRKCA | More | | Levosimendan | hsa05032 | Morphine addiction | 4.08E-02 | 5 | Q08828, P51828, P62873, Q13370, P17252 | ADCY1, ADCY7, GNB1, PDE3B, PRKCA | More | | Levosimendan | hsa05100 | Bacterial invasion of epithelial cells | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Levosimendan | hsa05110 | Vibrio cholerae infection | 6.20E-04 | 5 | Q13488, P17252, P19174, P60709, P63261 | TCIRG1, PRKCA, PLCG1, ACTB, ACTG1 | More | | Levosimendan | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.27E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Levosimendan | hsa05131 | Shigellosis | 1.91E-02 | 3 | P60709, P63261, P07384 | ACTB, ACTG1, CAPN1 | More | | Levosimendan | hsa05132 | Salmonella infection | 2.92E-05 | 15 | P51617, P01584, P25963, P08238, Q96RF0, Q13489, P10415, P04406, P08575, O75369, Q13561, Q13509, P68371, P49754, Q9NP90 | IRAK1, IL1B, NFKBIA, HSP90AB1, SNAG1, BIRC3, BCL2, GAPDH, PTPRC, FLNB, DCTN2, TUBB3, TUBB2C, VPS41, RAB9B | More | | Levosimendan | hsa05133 | Pertussis | 3.94E-04 | 5 | P0DP23, P01584, P23528, P09871, P51617 | CALM1, IL1B, CFL1, C1S, IRAK1 | More | | Levosimendan | hsa05135 | Yersinia infection | 3.88E-03 | 3 | P60709, P63261, Q16513 | ACTB, ACTG1, PKN2 | More | | Levosimendan | hsa05140 | Leishmaniasis | 1.16E-03 | 10 | P13612, O75015, P14598, P42224, P25963, P01375, P29350, P49006, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, STAT1, NFKBIA, TNF, PTPN6, MARCKSL1, MAPK14, NCF4 | More | | Levosimendan | hsa05143 | African trypanosomiasis | 3.87E-02 | 3 | P01584, P17252, P01042 | IL1B, PRKCA, KNG1 | More | | Levosimendan | hsa05145 | Toxoplasmosis | 5.28E-05 | 9 | P51617, P10415, Q13489, P23458, P42224, P31751, P11142, P29965, Q13651 | IRAK1, BCL2, BIRC3, JAK1, STAT1, AKT2, HSPA8, CD40LG, IL10RA | More | | Levosimendan | hsa05146 | Amoebiasis | 4.20E-02 | 5 | P09341, P14778, P27930, P01375, P05089 | CXCL1, IL1R1, IL1R2, TNF, ARG1 | More | | Levosimendan | hsa05161 | Hepatitis B | 1.31E-04 | 10 | P17252, P18848, P23458, Q13485, P31751, P10415, P27348, P01568, P42224, P51617 | PRKCA, ATF4, JAK1, SMAD4, AKT2, BCL2, YWHAQ, IFNA21, STAT1, IRAK1 | More | | Levosimendan | hsa05162 | Measles | 1.74E-04 | 10 | P51617, P01568, P23458, P42224, P14784, P31751, P11142, P01584, Q9NP90, P10415 | IRAK1, IFNA21, JAK1, STAT1, IL2RB, AKT2, HSPA8, IL1B, RAB9B, BCL2 | More | | Levosimendan | hsa05163 | Human cytomegalovirus infection | 3.30E-04 | 21 | P31751, P01375, P62873, P50151, P0DP23, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, P61073, P17252, Q13651, P25025, Q16539, P18848, O00463, P61769, P01568 | AKT2, TNF, GNB1, GNG10, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, CXCR4, PRKCA, IL10RA, CXCR2, MAPK14, ATF4, TRAF5, B2M, IFNA21 | More | | Levosimendan | hsa05164 | Influenza A | 7.10E-03 | 3 | P48551, P60709, P63261 | IFNAR2, ACTB, ACTG1 | More | | Levosimendan | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 5.71E-03 | 8 | P01568, P42224, P25963, P40189, P62873, P19174, P04141, P0DP23 | IFNA21, STAT1, NFKBIA, IL6ST, GNB1, PLCG1, CSF2, CALM1 | More | | Levosimendan | hsa05168 | Herpes simplex virus 1 infection | 5.39E-07 | 22 | P25963, P01568, P01584, Q9UBU9, Q9GZY0, P23458, P42224, Q07955, Q01130, Q13243, Q13489, P51617, P61769, P31751, Q13398, Q6P280, Q03923, P52738, O75820, Q9UDV6, P10415, Q14232 | NFKBIA, IFNA21, IL1B, NXF1, NXF2; NXF2B, JAK1, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, IRAK1, B2M, AKT2, ZNF211, ZNF529, ZNF85, ZNF140, ZNF189, ZNF212, BCL2, EIF2B1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.739 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P01568 | IFNA21 | Interferon alpha-21 | 0.729 | P0DP25 | CALM3 | Calmodulin-3 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01584 | IL1B | Interleukin-1 beta | 0.72 | P0DP24 | CALM2 | Calmodulin-2 | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.772 | P0DP23 | CALM1 | Calmodulin-1 | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.743 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q9GZY0 | NXF2; NXF2B | Nuclear RNA export factor 2 | 0.704 | P0DP24 | CALM2 | Calmodulin-2 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.738 | P0DP23 | CALM1 | Calmodulin-1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.822 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.912 | P0DP25 | CALM3 | Calmodulin-3 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.776 | P0DP25 | CALM3 | Calmodulin-3 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P0DP24 | CALM2 | Calmodulin-2 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P0DP23 | CALM1 | Calmodulin-1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.758 | P0DP25 | CALM3 | Calmodulin-3 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P0DP24 | CALM2 | Calmodulin-2 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P0DP23 | CALM1 | Calmodulin-1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.87 | P0DP25 | CALM3 | Calmodulin-3 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP24 | CALM2 | Calmodulin-2 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP23 | CALM1 | Calmodulin-1 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP25 | CALM3 | Calmodulin-3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP24 | CALM2 | Calmodulin-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP23 | CALM1 | Calmodulin-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP25 | CALM3 | Calmodulin-3 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P0DP24 | CALM2 | Calmodulin-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P0DP23 | CALM1 | Calmodulin-1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P0DP24 | CALM2 | Calmodulin-2 | P61769 | B2M | Beta-2-microglobulin | 0.787 | P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13398 | ZNF211 | Zinc finger protein 211 | -0.759 | P0DP25 | CALM3 | Calmodulin-3 | Q13398 | ZNF211 | Zinc finger protein 211 | 0.898 | P0DP24 | CALM2 | Calmodulin-2 | Q13398 | ZNF211 | Zinc finger protein 211 | 0.898 | P0DP23 | CALM1 | Calmodulin-1 | Q13398 | ZNF211 | Zinc finger protein 211 | 0.898 | P0DP23 | CALM1 | Calmodulin-1 | Q6P280 | ZNF529 | Zinc finger protein 529 | 0.767 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q03923 | ZNF85 | Zinc finger protein 85 | 0.79 | P0DP25 | CALM3 | Calmodulin-3 | Q03923 | ZNF85 | Zinc finger protein 85 | -0.818 | P0DP24 | CALM2 | Calmodulin-2 | Q03923 | ZNF85 | Zinc finger protein 85 | -0.818 | P0DP23 | CALM1 | Calmodulin-1 | Q03923 | ZNF85 | Zinc finger protein 85 | -0.818 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P52738 | ZNF140 | Zinc finger protein 140 | 0.717 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O75820 | ZNF189 | Zinc finger protein 189 | 0.715 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q9UDV6 | ZNF212 | Zinc finger protein 212 | -0.808 | P0DP25 | CALM3 | Calmodulin-3 | Q9UDV6 | ZNF212 | Zinc finger protein 212 | 0.759 | P0DP24 | CALM2 | Calmodulin-2 | Q9UDV6 | ZNF212 | Zinc finger protein 212 | 0.759 | P0DP23 | CALM1 | Calmodulin-1 | Q9UDV6 | ZNF212 | Zinc finger protein 212 | 0.759 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP23 | CALM1 | Calmodulin-1 | Q14232 | EIF2B1 | Translation initiation factor eIF-2B subunit alpha | 0.797 |
| Levosimendan | hsa05170 | Human immunodeficiency virus 1 infection | 4.12E-05 | 12 | P31751, P62873, P0DP23, P61073, P17252, P61769, P01568, P51617, P19174, P23528, P10415, Q9Y6Q5 | AKT2, GNB1, CALM1, CXCR4, PRKCA, B2M, IFNA21, IRAK1, PLCG1, CFL1, BCL2, AP1M2 | More | | Levosimendan | hsa05171 | Coronavirus disease - COVID-19 | 1.36E-02 | 7 | P25963, P42224, P01568, P40189, P04141, P19174, P17252 | NFKBIA, STAT1, IFNA21, IL6ST, CSF2, PLCG1, PRKCA | More | | Levosimendan | hsa05200 | Pathways in cancer | 3.38E-10 | 31 | P23458, P08238, P42224, P25963, P19174, Q15311, P17252, P43246, Q13485, P14923, P10415, Q13489, P49767, Q12778, P31751, Q08828, P51828, P62873, P61073, P78417, O75293, Q15788, P0DP23, Q13557, O43521, P01568, P14784, P40189, P16871, P00734, P01042 | JAK1, HSP90AB1, STAT1, NFKBIA, PLCG1, RALBP1, PRKCA, MSH2, SMAD4, JUP, BCL2, BIRC3, VEGFC, FOXO1, AKT2, ADCY1, ADCY7, GNB1, CXCR4, GSTO1, GADD45B, NCOA1, CALM1, CAMK2D, BCL2L11, IFNA21, IL2RB, IL6ST, IL7R, F2, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP24 | CALM2 | Calmodulin-2 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.738 | P0DP23 | CALM1 | Calmodulin-1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.822 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.826 | P0DP25 | CALM3 | Calmodulin-3 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.912 | P0DP25 | CALM3 | Calmodulin-3 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.739 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.739 | P0DP25 | CALM3 | Calmodulin-3 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP24 | CALM2 | Calmodulin-2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP23 | CALM1 | Calmodulin-1 | Q15311 | RALBP1 | RalA-binding protein 1 | 0.858 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P17252 | PRKCA | Protein kinase C alpha type | 0.832 | P0DP25 | CALM3 | Calmodulin-3 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP24 | CALM2 | Calmodulin-2 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP23 | CALM1 | Calmodulin-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.768 | P0DP25 | CALM3 | Calmodulin-3 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP24 | CALM2 | Calmodulin-2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP23 | CALM1 | Calmodulin-1 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP25 | CALM3 | Calmodulin-3 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP24 | CALM2 | Calmodulin-2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP23 | CALM1 | Calmodulin-1 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P14923 | JUP | Junction plakoglobin | 0.735 | P0DP25 | CALM3 | Calmodulin-3 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP25 | CALM3 | Calmodulin-3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP24 | CALM2 | Calmodulin-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP23 | CALM1 | Calmodulin-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P49767 | VEGFC | Vascular endothelial growth factor C | 0.761 | P0DP25 | CALM3 | Calmodulin-3 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP24 | CALM2 | Calmodulin-2 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP23 | CALM1 | Calmodulin-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q12778 | FOXO1 | Forkhead box protein O1 | 0.753 | P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | P0DP24 | CALM2 | Calmodulin-2 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.711 | P0DP23 | CALM1 | Calmodulin-1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.725 | P0DP23 | CALM1 | Calmodulin-1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.719 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.833 | P0DP25 | CALM3 | Calmodulin-3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP23 | CALM1 | Calmodulin-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.759 | P0DP25 | CALM3 | Calmodulin-3 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP24 | CALM2 | Calmodulin-2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP23 | CALM1 | Calmodulin-1 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.713 | P0DP25 | CALM3 | Calmodulin-3 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP23 | CALM1 | Calmodulin-1 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.731 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P0DP23 | CALM1 | Calmodulin-1 | -0.761 | P0DP25 | CALM3 | Calmodulin-3 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP23 | CALM1 | Calmodulin-1 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.786 | P0DP24 | CALM2 | Calmodulin-2 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.75 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P01568 | IFNA21 | Interferon alpha-21 | 0.729 | P0DP25 | CALM3 | Calmodulin-3 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP25 | CALM3 | Calmodulin-3 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP24 | CALM2 | Calmodulin-2 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP23 | CALM1 | Calmodulin-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P40189 | IL6ST | Interleukin-6 receptor subunit beta | -0.746 | P0DP23 | CALM1 | Calmodulin-1 | P16871 | IL7R | Interleukin-7 receptor subunit alpha | 0.718 | P0DP23 | CALM1 | Calmodulin-1 | P00734 | F2 | Prothrombin | -0.738 | P0DP25 | CALM3 | Calmodulin-3 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP24 | CALM2 | Calmodulin-2 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP23 | CALM1 | Calmodulin-1 | P01042 | KNG1 | Kininogen-1 | -0.71 |
| Levosimendan | hsa05204 | Chemical carcinogenesis | 3.70E-03 | 3 | P00325, P78417, P33260 | ADH1B, GSTO1, CYP2C18 | More | | Levosimendan | hsa05212 | Pancreatic cancer | 5.55E-03 | 6 | P31751, Q15311, P23458, P42224, Q13485, O75293 | AKT2, RALBP1, JAK1, STAT1, SMAD4, GADD45B | More | | Levosimendan | hsa05214 | Glioma | 6.69E-07 | 6 | P0DP23, Q13557, P17252, P31751, P19174, O75293 | CALM1, CAMK2D, PRKCA, AKT2, PLCG1, GADD45B | More | | Levosimendan | hsa05225 | Hepatocellular carcinoma | 1.85E-03 | 4 | Q92529, P51531, P60709, P63261 | SHC3, SMARCA2, ACTB, ACTG1 | More | | Levosimendan | hsa05231 | Choline metabolism in cancer | 2.25E-03 | 5 | Q9NRA1, Q9Y259, P19174, P23743, P17252 | PDGFC, CHKB, PLCG1, DGKA, PRKCA | More | | Levosimendan | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.97E-02 | 5 | P25963, P19174, P29350, P42224, P10747 | NFKBIA, PLCG1, PTPN6, STAT1, CD28 | More | | Levosimendan | hsa05410 | Hypertrophic cardiomyopathy | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Levosimendan | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 8.96E-03 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Levosimendan | hsa05414 | Dilated cardiomyopathy | 1.73E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Levosimendan | hsa05415 | Diabetic cardiomyopathy | 1.20E-02 | 6 | P17252, P14598, Q15080, Q16718, O14521, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, GAPDH | More | | Levosimendan | hsa05416 | Viral myocarditis | 8.96E-03 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Levosimendan | hsa05418 | Fluid shear stress and atherosclerosis | 3.99E-05 | 15 | Q16539, P42338, P14598, P78417, P10599, P14780, P01375, P60709, P63261, P10415, P14778, P27930, P0DP23, P08238, Q92974 | MAPK14, PIK3CB, NCF1, GSTO1, TXN, MMP9, TNF, ACTB, ACTG1, BCL2, IL1R1, IL1R2, CALM1, HSP90AB1, ARHGEF2 | More | | |